Prostacyclin is a potent prostaglandin class pharmaceutical primarily used to treat pulmonary arterial hypertension due to its ability to dilate blood vessels and inhibit platelet aggregation. This category… Read more

![Chemical structure of 5-((2R,3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)hexahydro-2H-2,5-epoxycyclopenta[b]furan-2-yl)pentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F91284-06-9-5-2R3aR4R5R6aS-4-SE-3-Hydroxyoct-1-en-1-ylhexahydro-2H-25-epoxycyclopentabfuran-2-ylpentanoic-acid.png&w=3840&q=75)
![Chemical structure of 5-((3aS,4R,5R,6aS)-5-Hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[b]furan-2-yl)pentanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F65870-86-2-5-3aS4R5R6aS-5-Hydroxy-4-SE-3-hydroxyoct-1-en-1-yl-3a566a-tetrahydro-4H-cyclopentabfuran-2-ylpentanoic-acid.png&w=3840&q=75)



Prostacyclin is a potent prostaglandin class pharmaceutical primarily used to treat pulmonary arterial hypertension due to its ability to dilate blood vessels and inhibit platelet aggregation. This category includes high-quality reference standards for the parent drug, its sodium salt, and associated degradation products, such as identified process-related and degradation-related impurities. Pharmaceutical laboratories utilize these materials for impurity profiling, allowing for the precise detection and quantification of related substances during rigorous quality control and stability testing. Furthermore, the inclusion of stable isotope labelled compounds, such as deuterium-labelled variants, provides essential internal standards for mass spectrometry and chromatography applications. These reference materials support method validation and enable researchers to ensure strict regulatory compliance throughout the drug development lifecycle, from initial analytical method establishment to batch release testing.